JAMA Otolaryngology–Head & Neck Surgery—The Year in Review, 2020 | Otolaryngology | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
[Skip to Navigation]
Views 256
Citations 0
March 25, 2021

JAMA Otolaryngology–Head & Neck Surgery—The Year in Review, 2020

Author Affiliations
  • 1Editor, JAMA Otolaryngology–Head & Neck Surgery
  • 2Department of Otolaryngology–Head and Neck Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri
JAMA Otolaryngol Head Neck Surg. Published online March 25, 2021. doi:10.1001/jamaoto.2021.0083

The year 2020 will be remembered as a most challenging year, and this was true at JAMA Otolaryngology–Head & Neck Surgery. Our editorial board meeting was held in Chicago, Illinois, on March 9, 2020, and while we discussed the emerging manifestations of the coronavirus disease 2019 (COVID-19) pandemic, we had little knowledge of how dramatically our lives were going to change in the next few days and weeks. I especially want to thank the editors, members of the editorial board, peer reviewers,1 authors, and members of the publication staff for their tremendous hard work and contributions to the journal this past year despite the burdens of the COVID-19 pandemic.

In 2020, the journal received 2040 manuscripts, which is 661 more manuscripts than we received in 2019, a 47.9% relative increase. The overall acceptance rate decreased to 15%, and of the 1363 research submissions in 2020, we published 109 (8.0%). Between April and December 2020, the journal received 317 COVID-19–related manuscripts. The journal received 127 Reviews and published 18 (14.2%) and received 101 Viewpoints and published 24 (23.8%). The journal published 4 clinical trials, 13 meta-analyses, and 7 systematic reviews. The content mix for 2020 was approximately 35% original research and 65% clinical review and education, letters, and opinion. Despite the tremendous increase in submissions, the journal was able to complete manuscript reviews in a timely fashion. The efforts of our reviewers and editors resulted in a median time from receipt of an original research report to publication of 119 days, a decrease of 36 days from 2019. The median time from acceptance to first publication was 61 days. Keeping the time between receipt and rejection short for manuscripts that are not suitable for peer review in the journal is important so that authors of rejected manuscripts may submit the manuscript elsewhere without inordinate delay. Also important is to ensure published results are made quickly available. All COVID-19 articles were made freely available to the world, and all research articles are freely available 12 months after publication on the journal’s website.

The journal received 138 submissions associated with the 2020 American Head and Neck Society (AHNS) meeting. With the outstanding effort by Deputy Editor Samir Khariwala, MD, MS, editorial manager Karen L. Dodson, MBA, and the staffs of the AHNS and the JAMA Network, we were able to quickly review and publish 7 articles online first and in the December issue despite the meeting being postponed to 2021.2-8

This past year, the journal’s impact factor increased from 3.5 to 3.8—the highest of all otorhinolaryngology journals. The immediacy index, or the average number of times an article is cited in the year it is published, is 1.049 and is the highest of all general otolaryngology journals. The quality of our published articles is reflected in the nearly 4 million article views and more than 3600 mentions of JAMA Otolaryngology–Head & Neck Surgery articles in news media in 2020. The electronic table of contents was provided via email to more than 40 000 readers. This past year, we also published 10 podcasts of interviews with authors. In 2020, we had more than 15 000 Twitter and Facebook followers. David M. Poetker, MD, Continuing Medical Education Editor, produced CME quizzes, which more than 2300 individuals used to claim CME credit. In addition, 232 peer reviewers and authors claimed CME credit for contributing to the journal.

The journal covered a wide range of topics across the subspecialties of otolaryngology, in addition to the COVID-19 pandemic, in the past year. The top 3 articles by views, Altmetric scores (measures of news and social media attention), and citations for 2020 are shown in the Table.9-15 Not surprisingly, most of these articles covered topics related to the testing for COVID-19 and clinical presentation of patients with COVID-19. The highest-rated article in terms of views and news and social media coverage was a report of the first case of a cerebrospinal fluid leak after nasal testing for COVID-19.9 The next 2 most read articles included studies that assessed the efficacy of nasal povidone-iodine against in vitro transmission of SARS-CoV-210 and examined the clinical course of the loss of sense of smell and taste in a case series of mildly symptomatic patients with SARS-CoV-2 infection.11 Another top-ranked article reported a study that found that cell phone–related injuries to the head and neck have increased steeply over the recent 20-year period, with many incidents resulting from distraction.12 Another important article reported on a patient who was diagnosed as having COVID-19 and presented mainly with olfactory function loss.13 At that time in the COVID-19 pandemic, this finding had not been previously reported in the published literature. This report was submitted to the journal on March 20, 2020, and expedited for publication 19 days later on April 8, 2020.

Table.  JAMA Otolaryngology–Head & Neck Surgery Statistics for 2020
JAMA Otolaryngology–Head & Neck Surgery Statistics for 2020

The journal published 12 Original Investigations and Research Letters focused on COVID-19, including the presenting signs and symptoms,16 clinical course,11 treatment,10,17 modifications of techniques to increase safety,18-21 and health services research.22 The journal also published 4 Reflections, which poignantly described first-person experiences with COVID-19.23-26 Last year, the journal published 5 Patient Pages: “What Are Ear Tubes?”27 “Nasal Airway Obstruction Structure and Function,”28 “Thyroid Nodules,”29 “Laryngectomy Care in the COVID-19 Era,”30 and “Immunotherapy.”31

This year, the journal will start to publish visual abstracts with all reports of randomized clinical trials. Visual abstracts are graphic summaries of the main aspects of the clinical trial, including the population, location, intervention, and findings. Through the use of pictographs and minimal words, visual abstracts convey complex trial information in an efficient way. The journal’s first visual abstract, published on March 4, 2021, summarizes a clinical trial of the effect of oral corticosteroids following endoscopic sinus surgery for chronic rhinosinusitis without nasal polyposis.32

I wish to acknowledge the tremendous work and effort on behalf of the journal by Samir Khariwala (focusing on head and neck) and Deputy Editor Cristina Baldassari, MD (focusing on pediatrics), as well as the journal’s associate editors and section editors.33 I also thank Joseph P. Bradley, MD, for his great work as online editor and host for the journal’s podcast. I welcome Nosayaba (Nosa) Osazuwa-Peters, PhD, MPH, as the newest member of the Editorial Board. And finally, a repeated special thanks to our reviewers,1 who so generously give their time to review submissions, which ultimately leads to the high-quality content within the journal.

I invite all of you to sign up for the electronic table of contents at https://jamaotolaryngology.com, follow us on Twitter @JAMAOto, or friend us on Facebook.

Back to top
Article Information

Corresponding Author: Jay F. Piccirillo, MD, Department of Otolaryngology–Head and Neck Surgery, Washington University in St Louis School of Medicine, 660 S Euclid Ave, Campus Box 8115, St Louis, MO 63110 (piccirij@wustl.edu).

Published Online: March 25, 2021. doi:10.1001/jamaoto.2021.0083

Conflict of Interest Disclosures: None reported.

 JAMA Otolaryngology–Head & Neck Surgery peer reviewers in 2020.   JAMA Otolaryngol Head Neck Surg. Published online March 25, 2021. doi:10.1001/jamaoto.2021.0116Google Scholar
Nathan  CO, Fakhry  C, Moore  MG.  We survived 2020 with patient survivors: presidential address.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1097-1098. doi:10.1001/jamaoto.2020.4088PubMedGoogle ScholarCrossref
Osazuwa-Peters  N, Graboyes  EM, Khariwala  SS.  Expanding indications for the human papillomavirus vaccine: one small step for the prevention of head and neck cancer, but one giant leap remains.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1099-1101. doi:10.1001/jamaoto.2020.4068PubMedGoogle ScholarCrossref
Malik  A, Nair  S, Sonawane  K,  et al.  Outcomes of a telephone-based questionnaire for follow-up of patients who have completed curative-intent treatment for oral cancers.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1102-1108. doi:10.1001/jamaoto.2020.2404PubMedGoogle ScholarCrossref
Yan  F, Li  H, Kaczmar  JM,  et al.  Evaluating adjuvant therapy with chemoradiation vs radiation alone for patients with HPV-negative N2a head and neck cancer.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1109-1119. doi:10.1001/jamaoto.2020.2107PubMedGoogle ScholarCrossref
Liu  JC-J, Kupferman  M, Kraus  D.  Characteristics and outcomes of research funded by the American Head and Neck Society Foundation.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1120-1124. doi:10.1001/jamaoto.2020.3054PubMedGoogle ScholarCrossref
Noel  CW, Sutradhar  R, Li  Q,  et al.  Association of immigration status and Chinese and South Asian ethnicity with incidence of head and neck cancer.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1125-1135. doi:10.1001/jamaoto.2020.4197PubMedGoogle ScholarCrossref
Izreig  S, Alzahrani  F, Earles  J,  et al.  Hyperprogression of a sinonasal squamous cell carcinoma following programmed cell death protein-1 checkpoint blockade.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1176-1178. doi:10.1001/jamaoto.2020.2584PubMedGoogle ScholarCrossref
Sullivan  CB, Schwalje  AT, Jensen  M,  et al.  Cerebrospinal fluid leak after nasal swab testing for coronavirus disease 2019.   JAMA Otolaryngol Head Neck Surg. 2020;146(12):1179-1181. doi:10.1001/jamaoto.2020.3579PubMedGoogle ScholarCrossref
Frank  S, Brown  SM, Capriotti  JA, Westover  JB, Pelletier  JS, Tessema  B.  In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2.   JAMA Otolaryngol Head Neck Surg. 2020;146(11):1054-1058. doi:10.1001/jamaoto.2020.3053PubMedGoogle ScholarCrossref
Boscolo-Rizzo  P, Borsetto  D, Fabbris  C,  et al.  Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19.   JAMA Otolaryngol Head Neck Surg. 2020;146(8):729-732. doi:10.1001/jamaoto.2020.1379PubMedGoogle ScholarCrossref
Povolotskiy  R, Gupta  N, Leverant  AB, Kandinov  A, Paskhover  B.  Head and neck injuries associated with cell phone use.   JAMA Otolaryngol Head Neck Surg. 2020;146(2):122-127. doi:10.1001/jamaoto.2019.3678PubMedGoogle ScholarCrossref
Eliezer  M, Hautefort  C, Hamel  AL,  et al.  Sudden and complete olfactory loss of function as a possible symptom of COVID-19.   JAMA Otolaryngol Head Neck Surg. 2020;146(7):674-675. doi:10.1001/jamaoto.2020.0832PubMedGoogle ScholarCrossref
Givi  B, Schiff  BA, Chinn  SB,  et al.  Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic.   JAMA Otolaryngol Head Neck Surg. 2020;146(6):579-584. doi:10.1001/jamaoto.2020.0780PubMedGoogle ScholarCrossref
Tay  JK, Khoo  ML-C, Loh  WS.  Surgical considerations for tracheostomy during the COVID-19 pandemic: lessons learned from the severe acute respiratory syndrome outbreak.   JAMA Otolaryngol Head Neck Surg. 2020;146(6):517-518. doi:10.1001/jamaoto.2020.0764PubMedGoogle ScholarCrossref
Mercante  G, Ferreli  F, De Virgilio  A,  et al.  Prevalence of taste and smell dysfunction in coronavirus disease 2019.   JAMA Otolaryngol Head Neck Surg. 2020;146(8):723-728. doi:10.1001/jamaoto.2020.1155PubMedGoogle ScholarCrossref
Kwak  PE, Connors  JR, Benedict  PA,  et al.  Early outcomes from early tracheostomy for patients with COVID-19.   JAMA Otolaryngol Head Neck Surg. Published online December 17, 2020. doi:10.1001/jamaoto.2020.4837PubMedGoogle Scholar
Pollaers  K, Herbert  H, Vijayasekaran  S.  Pediatric microlaryngoscopy and bronchoscopy in the COVID-19 era.   JAMA Otolaryngol Head Neck Surg. 2020;146(7):608-612. doi:10.1001/jamaoto.2020.1191PubMedGoogle ScholarCrossref
Bertroche  JT, Pipkorn  P, Zolkind  P, Buchman  CA, Zevallos  JP.  Negative-pressure aerosol cover for COVID-19 tracheostomy.   JAMA Otolaryngol Head Neck Surg. 2020;146(7):672-674. doi:10.1001/jamaoto.2020.1081PubMedGoogle ScholarCrossref
Carron  JD, Buck  LS, Harbarger  CF, Eby  TL.  A simple technique for droplet control during mastoid surgery.   JAMA Otolaryngol Head Neck Surg. 2020;146(7):671-672. doi:10.1001/jamaoto.2020.1064PubMedGoogle ScholarCrossref
Frazier  KM, Hooper  JE, Mostafa  HH, Stewart  CM.  SARS-CoV-2 virus isolated from the mastoid and middle ear: implications for COVID-19 precautions during ear surgery.   JAMA Otolaryngol Head Neck Surg. 2020;146(10):964-966. doi:10.1001/jamaoto.2020.1922PubMedGoogle ScholarCrossref
Tam  S, Wu  VF, Williams  AM,  et al.  Disparities in the uptake of telemedicine during the COVID-19 surge in a multidisciplinary head and neck cancer population by patient demographic characteristics and socioeconomic status.   JAMA Otolaryngol Head Neck Surg. 2020;147(2):209-211. doi:10.1001/jamaoto.2020.3052PubMedGoogle ScholarCrossref
Horton  JD.  To be a partner in life-resident training during the COVID-19 pandemic.   JAMA Otolaryngol Head Neck Surg. 2020;146(7):601-602. doi:10.1001/jamaoto.2020.0921PubMedGoogle ScholarCrossref
Yueh  B.  The worst patient—a physician with COVID-19.   JAMA Otolaryngol Head Neck Surg. 2020;146(10):891-892. doi:10.1001/jamaoto.2020.2435PubMedGoogle ScholarCrossref
Cosetti  MK.  Hearing from the COVID-19 epicenter—a neurotologist’s reflection from the front lines.   JAMA Otolaryngol Head Neck Surg. 2020;146(10):889-890. doi:10.1001/jamaoto.2020.2532PubMedGoogle ScholarCrossref
Badhey  AK, Laitman  BM.  If not us, who? and if not now, when? perspective from a COVID-19 intensive care unit run by otolaryngology residents.   JAMA Otolaryngol Head Neck Surg. 2020;146(11):997-998. doi:10.1001/jamaoto.2020.3232PubMedGoogle ScholarCrossref
Lawlor  C.  What are ear tubes?   JAMA Otolaryngol Head Neck Surg. 2020;147(1):116. doi:10.1001/jamaoto.2020.2753PubMedGoogle ScholarCrossref
Teitelbaum  JI, Barrett  DM.  Nasal airway obstruction structure and function.   JAMA Otolaryngol Head Neck Surg. 2020;146(5):512. doi:10.1001/jamaoto.2020.0165PubMedGoogle ScholarCrossref
Wu  J.  Thyroid nodules.   JAMA Otolaryngol Head Neck Surg. 2020;146(6):596. doi:10.1001/jamaoto.2020.0264PubMedGoogle ScholarCrossref
Sarsfield  E, Montano  M, Choi  K, Goyal  N.  Laryngectomy care in the COVID-19 era.   JAMA Otolaryngol Head Neck Surg. 2020;146(8):776. doi:10.1001/jamaoto.2020.1523PubMedGoogle ScholarCrossref
Marcus  S.  Immunotherapy.   JAMA Otolaryngol Head Neck Surg. 2020;146(10):988. doi:10.1001/jamaoto.2020.1798PubMedGoogle ScholarCrossref
Chang  MT, Noel  J, Ayoub  NF,  et al.  Oral corticosteroids following endoscopic sinus surgery for chronic rhinosinusitis without nasal polyposis: a randomized clinical trial.   JAMA Otolaryngol Head Neck Surg. Published online March 4, 2021. doi:10.1001/jamaoto.2021.0011Google Scholar
 JAMA Otolaryngology–Head & Neck Surgery.   JAMA Otolaryngol Head Neck Surg. 2021;147(1):3. doi:10.1001/jamaoto.2020.3342PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words